Moderna Inc (MRNA)
37.71
+0.77
(+2.08%)
USD |
NASDAQ |
Nov 21, 14:30
Moderna Price: 37.71 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 37.29 | 38.22 | 36.41 | 36.94 | 7.279M |
| Nov 19, 2024 | 38.90 | 39.28 | 37.01 | 37.29 | 9.149M |
| Nov 18, 2024 | 38.31 | 39.76 | 37.10 | 39.51 | 13.88M |
| Nov 15, 2024 | 38.55 | 38.70 | 35.80 | 36.85 | 24.36M |
| Nov 14, 2024 | 42.05 | 42.06 | 38.76 | 39.77 | 12.89M |
| Nov 13, 2024 | 43.25 | 43.28 | 41.71 | 42.14 | 7.725M |
| Nov 12, 2024 | 42.19 | 44.11 | 41.54 | 43.47 | 10.71M |
| Nov 11, 2024 | 46.83 | 46.88 | 42.25 | 42.75 | 15.92M |
| Nov 08, 2024 | 50.42 | 50.90 | 46.57 | 46.83 | 13.56M |
| Nov 07, 2024 | 56.60 | 56.70 | 49.94 | 50.28 | 18.21M |
| Nov 06, 2024 | 52.61 | 52.86 | 49.60 | 51.81 | 10.68M |
| Nov 05, 2024 | 53.53 | 54.32 | 52.08 | 53.29 | 5.766M |
| Nov 04, 2024 | 54.60 | 55.65 | 53.41 | 53.54 | 4.037M |
| Nov 01, 2024 | 54.49 | 55.35 | 53.89 | 54.63 | 4.787M |
| Oct 31, 2024 | 54.35 | 54.58 | 52.92 | 54.36 | 4.511M |
| Oct 30, 2024 | 54.37 | 55.04 | 53.50 | 54.72 | 4.281M |
| Oct 29, 2024 | 55.21 | 57.69 | 54.88 | 55.22 | 5.593M |
| Oct 28, 2024 | 53.31 | 55.77 | 53.10 | 54.80 | 5.012M |
| Oct 25, 2024 | 53.01 | 54.51 | 52.80 | 53.09 | 3.704M |
| Oct 24, 2024 | 53.39 | 53.84 | 52.26 | 52.80 | 3.767M |
| Oct 23, 2024 | 53.22 | 54.74 | 52.77 | 53.39 | 4.289M |
| Oct 22, 2024 | 53.67 | 54.79 | 52.81 | 53.40 | 3.560M |
| Oct 21, 2024 | 53.82 | 54.76 | 53.05 | 53.80 | 4.092M |
| Oct 18, 2024 | 54.54 | 55.10 | 53.55 | 54.10 | 6.755M |
| Oct 17, 2024 | 57.08 | 57.14 | 54.82 | 54.82 | 5.424M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
17.78
Minimum
Jan 07 2020
484.47
Maximum
Aug 09 2021
135.71
Average
125.67
Median
Oct 04 2022
Price Benchmarks
| Eli Lilly and Co | 750.81 |
| Merck & Co Inc | 99.28 |
| Pfizer Inc | 25.02 |
| Novavax Inc | 8.12 |
| Vertex Pharmaceuticals Inc | 449.40 |
Price Related Metrics
| PS Ratio | 2.885 |
| Price to Book Value | 1.217 |
| Earnings Yield | -15.43% |
| Market Cap | 14.51B |